Latest Breaking News On - Arxx therapeutics - Page 1 : comparemela.com

Oncoinvent AS: Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board

Oncoinvent AS: Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomBristol myers squibbDennis riedlPronova biopharmaHochschule hannoverClavis pharmasIngrid teigland akayTroy larsenHilde steinegerCourtney mogerleyStrongbridge biopharmaGillies obryanAnne cecilie alvikLinear energy transferFusion pharmaceuticals

Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board

Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofIngrid teigland akayHilde steinegerAnne cecilie alvikTroy larsenCourtney mogerleyHochschule hannoverClavis pharmasGillies obryanPronova biopharmaStrongbridge biopharmaBristol myers squibbUniversity of osloLondon business schoolFusion pharmaceuticals

Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board

Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced the appointment of newly elected members of its Board of Directors (BOD) and the formation of a Scientific and Clinical.

City ofUnited kingdomIngrid teigland akayGillies obryanHochschule hannoverPronova biopharmaAnne cecilie alvikHilde steinegerClavis pharmasTroy larsenStrongbridge biopharmaBristol myers squibbLondon business schoolNycomed imaging amersham health now ge healthcareFusion pharmaceuticalsCranfield school of management

Series A supports company launch to advance disease therapies

With a shared focus on developing disease modulating treatments, Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx) have merged to form a new clinical stage company, Calluna Pharma Inc. Click to read more.

Antoine boulangerCalluna pharmaOxitope pharmaForbion ventures fundCalluna pharma incArxx therapeuticsChief executive officerManaging partnerSusanne stuffers

Calluna Pharma announces €75m series A financing for immunological diseases

Calluna Pharma announces €75m series A financing for immunological diseases
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Oxitope pharmaCalluna pharmaArxx therapeutics